UroGen Pharma Ltd. (URGN) › Shares OutstandingUroGen Pharma Ltd. (URGN) — Shares OutstandingAnnual figures by period end, from SEC filings.2016-12-31: 2.31M2017-12-31: 13.75M2018-12-31: 16.21M2019-12-31: 21.03M2020-12-31: 22.17M2021-12-31: 22.46M2022-12-31: 23.13M2023-12-31: 32.49M2024-12-31: 42.23M2025-12-31: 48.35M48.35M2016-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-3148.35M+14.5%2026-03-02Balance as of period end2024-12-3142.23M+30.0%2026-03-02Balance as of period end2023-12-3132.49M+40.5%2025-03-10Balance as of period end2022-12-3123.13M+3.0%2024-03-14Balance as of period end2021-12-3122.46M+1.3%2023-03-24Balance as of period end2020-12-3122.17M+5.4%2022-03-21Balance as of period end2019-12-3121.03M+29.7%2021-03-18Balance as of period end2018-12-3116.21M+17.9%2020-03-02Balance as of period end2017-12-3113.75M+496.4%2019-02-28Balance as of period end2016-12-312.31M—2018-03-15Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)